![[Avant et Arrière] Capteur usure plaquettes de frein pour 2012 BMW 328i xDrive 3.0L KSE-100213 2012-acura-tl Numéro de pièce: KBC-100312 KDA-100498](https://cdn.shopify.com/s/files/1/0642/1105/8866/files/KSE-100213-Box-01_26be7aa8-b749-45a7-a70e-effccb30a189.jpg?v=1771568406)
[Avant et Arrière] Capteur usure plaquettes de frein pour 2012 BMW 328i xDrive 3.0L KSE-100213 2012-acura-tl Numéro de pièce: KBC-100312 KDA-100498
EUR95.30EUR135.30
Pay in 4 interest-free payments of $23.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
Harbor notes
Description
[Avant et Arrière] Capteur usure plaquettes de frein pour 2012 BMW 328i xDrive 3.0L KSE 100213 2012 acura tl Numéro de pièce: KBC 100312 KDA 100498 Numéro de pièce: KBC 100312 65054 BR54035 54146 4886576 74886576 24886576 125494 66576 BD125494 ASR 54146 7532 PF7532M SS7532M SS7532X AD7532 QE7532M UP7532X D652 652 xCMX D652 Produit: Capteur usure plaquettes de frein Véhicules (consultez le tableau d'ajustement pour des informations détaillées sur le fitment):
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for [Avant et Arrière] Capteur usure plaquettes de frein pour 2012 BMW 328i xDrive 3.0L KSE-100213 2012-acura-tl Numéro de pièce: KBC-100312 KDA-100498
What should I check when reading a translated product listing?
Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.
How can I make a useful comparison table for several products?
Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.
How can I check whether a purchase involves ongoing commitments?
Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.